Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a revaluation of the cash element of the notional investment held within the US Retirement Savings Plan (The Plan), which is notionally held in GSK American Depositary Shares (ADSs), the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 18 March 2013 of an increase in the notional allocation of ADSs on 15 March 2013 at a price of $45.30 per ADS:-
Director/PDMR
|
Number of ADSs |
Connected Person |
Number of ADSs |
Dr M M Slaoui
|
20 |
Dr K Slaoui |
30 |
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
18 March 2013